PRJNA858501
Lung microbiome dysbiosis in  lower airway in progression of lung cancer.
The difference in lung microbiota between LC patients and patients with non-lung cancer was detected by metagenomics, with the purpose of exploring the interaction between lung microbiota and lung cancer.